Scientech Research’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
Other funds holding AQST
BCM
Scientech Research's AQST Position: Q2 2026 in Review
Scientech Research sold out of Aquestive Therapeutics (AQST) in Q2 2026, closing a stake of 13,181 shares — an estimated $54.7K sold.
Scientech Research first reported a position in AQST in Q3 2025 and held it in 3 quarters. The position peaked at $113K in Q3 2025. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.
- Scientech Research reported no remaining Aquestive Therapeutics position as of Q2 2026 after selling out during the quarter.
- Scientech Research sold 13,181 Aquestive Therapeutics shares in Q2 2026, an estimated $54.7K.
- Scientech Research first reported a position in Aquestive Therapeutics in Q3 2025 and held it in 3 quarters.
- Scientech Research's Aquestive Therapeutics position peaked at $113K in Q3 2025.
- 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.